P2 receptor-mediated inhibition of adenylyl cyclase in PC12 cells

被引:7
|
作者
Murayama, T [1 ]
Yakushi, Y [1 ]
Watanabe, A [1 ]
Nomura, Y [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 060, Japan
关键词
PC12; cell; ATP; cAMP; P2Y receptor;
D O I
10.1016/S0014-2999(98)00130-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PC12 pheochromocytoma cells have P2 receptors which are coupled to Ca2+ influx and catecholamine release. Previously we reported that ATP stimulated cyclic AMP accumulation at low concentrations up to 100 mu M but showed inhibitory effects above this concentration [Yakushi, Y., Watanabe, A., Murayama, T., Nomura, Y., 1996. Eur. J. Pharmacol. (314) 243-248]. In this study we investigated the characteristics of the inhibitory effects of ATP analogs. In the presence of 10 mu M forskolin, an activator of adenylyl cyclase, ATP, adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S), 2',3'-O-(4-benzoyl) benzoyl ATP, 2-methylthio ATP and adenosine 5'-O-(2-thiodiphosphate) inhibited cyclic AMP accumulation in a dose-dependent manner from 100 mu M. UTP, alpha beta and beta gamma-methylene ATP had no or very limited effects. The relative order of ATP analogs suggests that the ATP receptor appears to be P2Y-like. However, suramin, an antagonist of P2X and P2Y receptors, and reactive blue-2, which inhibited beta gamma-methylene ATP-induced cyclic AMP accumulation, did not modify the inhibitory effect of ATP gamma S. Treatment with pertussis toxin, which completely abolished the effect of carbachol, had no effect on the action of ATP over 300 mu M. The existence of a new type of ATP receptor-mediated inhibition of adenylyl cyclase is proposed in PC12 cells. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 50 条
  • [1] P-2 purinoceptor-mediated stimulation of adenylyl cyclase in PC12 cells
    Yakushi, Y
    Watanabe, A
    Murayama, T
    Nomura, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (1-2) : 243 - 248
  • [2] Inhibition of adenylyl cyclase activity in PC12 cells via P2Y receptors.
    Unterberger, U
    Boehm, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R32 - R32
  • [3] RECONSTITUTION OF MUSCARINIC RECEPTOR-MEDIATED INHIBITION OF ADENYLYL CYCLASE
    TOTA, MR
    XIA, ZQ
    STORM, DR
    SCHIMERLIK, MI
    MOLECULAR PHARMACOLOGY, 1990, 37 (06) : 950 - 957
  • [4] P2Y receptor-mediated inhibition of voltage-activated Ca2+ currents in PC12 cells
    Vartian, N
    Boehm, S
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 13 (05) : 899 - 908
  • [5] Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells
    Keikou Oka
    T. Andoh
    Itaru Watanabe
    Yoshinori Kamiya
    Hideki Ito
    Pflügers Archiv, 1998, 436 : 887 - 893
  • [6] Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells
    Oka, K
    Andoh, T
    Watanabe, I
    Kamiya, Y
    Ito, H
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1998, 436 (06): : 887 - 893
  • [7] Analysis of the involvement of the adenylyl cyclase pathway in the P2Y12-receptor-mediated inhibition of calcium influx in processes of PC12-cells
    von Kügelgen, I
    Kulick, MB
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R34 - R34
  • [8] Endogenous adenosine facilitates adenylyl cyclase activation in PC12 cells
    Frausin, F
    Florio, C
    Vertua, R
    Gaion, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R132 - R132
  • [9] The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells
    Kudlacek, O
    Just, H
    Korkhov, VM
    Vartian, N
    Klinger, M
    Pankevych, H
    Yang, Q
    Nanoff, C
    Freissmuth, M
    Boehm, S
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (07) : 1317 - 1327
  • [10] The Human D2 Dopamine Receptor Synergizes with the A2A Adenosine Receptor to Stimulate Adenylyl Cyclase in PC12 Cells
    Oliver Kudlacek
    Herwig Just
    Vladimir M Korkhov
    Nina Vartian
    Markus Klinger
    Halyna Pankevych
    Qiong Yang
    Christian Nanoff
    Michael Freissmuth
    Stefan Boehm
    Neuropsychopharmacology, 2003, 28 : 1317 - 1327